Elanco Animal Health Inc ELAN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ELAN is a good fit for your portfolio.
News
-
Elanco's 'Parvo is Poop' Campaign Unleashes Awareness and Action on National Parvo Awareness Day
-
Elanco's 'Parvo is Poop' Campaign Unleashes Awareness and Action on National Parvo Awareness Day
-
Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement
-
Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors
-
The Cow is the How: Elanco Sees Methane Reduction as New Value Opportunity
-
Elanco Appoints Shiv O'Neill as General Counsel and Corporate Secretary
-
Elanco Animal Health is Executing on Plan to Deliver for Shareholders
-
Ancora Nominates Four Highly Qualified, Independent Director Candidates and Urges Orderly CEO Succession at Elanco Animal Health
Trading Information
- Previous Close Price
- $13.57
- Day Range
- $13.11–13.55
- 52-Week Range
- $7.88–16.88
- Bid/Ask
- $11.78 / $13.49
- Market Cap
- $6.50 Bil
- Volume/Avg
- 4.2 Mil / 4.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 14.80
- Price/Sales
- 1.47
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company's operations are conducted globally and sell its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production. The company's product portfolio of approximately 200 brands.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 9,800
- Website
- https://www.elanco.com
Comparables
Valuation
|
Metric
|
ELAN
|
ZTS
|
PAHC
|
|---|---|---|---|
Price/Earnings (Normalized) | 14.80 | 29.93 | 14.64 |
Price/Book Value | 1.04 | 14.61 | 2.50 |
Price/Sales | 1.47 | 8.62 | 0.69 |
Price/Cash Flow | 11.35 | 25.69 | 12.75 |
Price/Earnings
ELAN
ZTS
PAHC
Financial Strength
|
Metric
|
ELAN
|
ZTS
|
PAHC
|
|---|---|---|---|
Quick Ratio | 1.10 | 1.77 | 1.30 |
Current Ratio | 2.75 | 3.36 | 3.12 |
Interest Coverage | −3.31 | 12.85 | 2.16 |
Quick Ratio
ELAN
ZTS
PAHC
Profitability
|
Metric
|
ELAN
|
ZTS
|
PAHC
|
|---|---|---|---|
Return on Assets (Normalized) | 2.90% | 17.35% | 0.94% |
Return on Equity (Normalized) | 6.35% | 52.06% | 3.34% |
Return on Invested Capital (Normalized) | 5.13% | 21.87% | 2.82% |
Return on Assets
ELAN
ZTS
PAHC
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Yphbbmrfn | Zskg | $72.8 Bil | |
MKKGY
| Merck KGaA ADR | Swmvczrwqx | Vwsrbz | $69.4 Bil | |
HLN
| Haleon PLC ADR | Nmvkbphm | Zncm | $38.9 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Cljzfcjc | Vjgb | $15.9 Bil | |
VTRS
| Viatris Inc | Qlxsbgs | Kpbt | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Fvsgkhtf | Rdl | $12.4 Bil | |
CTLT
| Catalent Inc | Wymlgsnym | Ssrfwfs | $10.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Xdwmzdn | Qlnz | $4.6 Bil | |
PRGO
| Perrigo Co PLC | Nnjjslyk | Jjcf | $4.4 Bil | |
GTBIF
| Green Thumb Industries Inc | Dbrprbhqtr | Hbyk | $3.7 Bil |